Cargando…

TNF receptor-associated factor 3 restrains B-cell receptor signaling in normal and malignant B cells

TRAF3 has diverse signaling functions, which vary by cell type. Uniquely in B lymphocytes, TRAF3 inhibits homeostatic survival. Highlighting the role of TRAF3 as a tumor suppressor, loss-of-function TRAF3 mutations are associated with human B-cell malignancies, while B-cell-specific deletion of TRAF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whillock, Amy L., Ybarra, Tiffany K., Bishop, Gail A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Biochemistry and Molecular Biology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042179/ https://www.ncbi.nlm.nih.gov/pubmed/33639170 http://dx.doi.org/10.1016/j.jbc.2021.100465

Ejemplares similares

TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cells
por: Whillock, Amy L., et al.
Publicado: (2019)

Author Correction: TRAF3 regulates the oncogenic proteins Pim2 and c-Myc to restrain survival in normal and malignant B cells
por: Whillock, Amy L., et al.
Publicado: (2019)

The adaptor molecule TRAF3 restrains the lineage determination of thymic regulatory T cells by modulating interleukin-2 receptor signaling
por: Yi, Zuoan, et al.
Publicado: (2014)

The role of the aryl hydrocarbon receptor in normal and malignant B cell development
por: Sherr, David H., et al.
Publicado: (2013)

B Cell Receptor Signaling and Protein Kinase D2 Support Regulatory B Cell Function in Pancreatic Cancer
por: Michaud, Daniel, et al.
Publicado: (2022)

Modulation of B-cell receptor and microenvironment signaling by a guanine exchange factor in B-cell malignancies
por: Liao, Wei, et al.
Publicado: (2016)

TNF receptor associated factor 3 plays a key role in development and function of invariant natural killer T cells
por: Yi, Zuoan, et al.
Publicado: (2013)

NR4A nuclear receptors restrain B cell responses to antigen when second signals are absent or limiting
por: Tan, Corey, et al.
Publicado: (2020)

Mechanisms of B Cell Receptor Activation and Responses to B Cell Receptor Inhibitors in B Cell Malignancies
por: Efremov, Dimitar G., et al.
Publicado: (2020)

Human CD38 regulates B cell antigen receptor dynamic organization in normal and malignant B cells
por: Camponeschi, Alessandro, et al.
Publicado: (2022)

Entry of B Cell Receptor into Signaling Domains Is Inhibited in Tolerant B Cells
por: Weintraub, Bennett C., et al.
Publicado: (2000)

Signaling Proteins and Transcription Factors in Normal and Malignant Early B Cell Development
por: Pérez-Vera, Patricia, et al.
Publicado: (2011)

STING regulates BCR signaling in normal and malignant B cells
por: Tang, Chih-Hang Anthony, et al.
Publicado: (2020)

Immunoproteasome Inhibition Impairs T and B Cell Activation by Restraining ERK Signaling and Proteostasis
por: Schmidt, Christian, et al.
Publicado: (2018)

B-cell colony growth of malignant and normal B-cells.
por: Kluin-Nelemans, J. C., et al.
Publicado: (1987)

Cucurbitacin B Down-Regulates TNF Receptor 1 Expression and Inhibits the TNF-α-Dependent Nuclear Factor κB Signaling Pathway in Human Lung Adenocarcinoma A549 Cells
por: Kusagawa, Eiichi, et al.
Publicado: (2022)

Terminating B cell receptor signaling
por: Mohammad, Dara K., et al.
Publicado: (2017)

Chimeric Antigen Receptor Therapy for B-cell Malignancies
por: Porter, David L, et al.
Publicado: (2011)

A and B Antigens of Normal and Malignant Cells
por: Kay, H. E. M.
Publicado: (1957)

Silencing of B Cell Receptor Signals in Human Naive B Cells
por: Feldhahn, Niklas, et al.
Publicado: (2002)

Role of TNF–TNF Receptor 2 Signal in Regulatory T Cells and Its Therapeutic Implications
por: Yang, Sujuan, et al.
Publicado: (2018)

JunB promotes Th17 cell identity and restrains alternative CD4(+) T-cell programs during inflammation
por: Carr, Tiffany M., et al.
Publicado: (2017)

CD20 is dispensable for B-cell receptor signaling but is required for proper actin polymerization, adhesion and migration of malignant B cells
por: Kozlova, Veronika, et al.
Publicado: (2020)

TLR7/TLR9- and B Cell Receptor-Signaling Crosstalk: Promotion of Potentially Dangerous B Cells
por: Suthers, Amy N., et al.
Publicado: (2017)

Toll-like receptors in the pathogenesis of human B cell malignancies
por: Isaza-Correa, Johana M, et al.
Publicado: (2014)

Targeting B cell malignancies through human B cell receptor specific CD4 T cells
por: Weng, Jinsheng, et al.
Publicado: (2015)

Interferon-γ Receptor Signaling in Dendritic Cells Restrains Spontaneous Proliferation of CD4(+) T Cells in Chronic Lymphopenic Mice
por: Knop, Laura, et al.
Publicado: (2019)

AWP1 Restrains the Aggressive Behavior of Breast Cancer Cells Induced by TNF-α
por: Kim, Eun-Young, et al.
Publicado: (2021)

Igβ tyrosine residues contribute to the control of B cell receptor signaling by regulating receptor internalization
por: Gazumyan, Anna, et al.
Publicado: (2006)

Selective killing of malignant B cells using T cells redirected against malignancy variant receptor
por: Han, Chungyong, et al.
Publicado: (2014)

Receptor Editing Occurs Frequently during Normal B Cell Development
por: Retter, Marc W., et al.
Publicado: (1998)

MiRNA-128-3p Restrains Malignant Melanoma Cell Malignancy by Targeting NTRK3
por: Zhou, Xinxin, et al.
Publicado: (2021)

Heterogeneity of Toll-like receptor 9 signaling in B cell malignancies and its potential therapeutic application
por: Bai, Ling, et al.
Publicado: (2017)

Crosslinking of CD38 Receptors Triggers Apoptosis of Malignant B Cells
por: Gambles, M. Tommy, et al.
Publicado: (2021)

Editorial: Role of the antigen receptor in the pathogenesis of B-cell lymphoid malignancies
por: Agathangelidis, Andreas, et al.
Publicado: (2023)

The B Cell Antigen Receptor and Overexpression of MYC Can Cooperate in the Genesis of B Cell Lymphomas
por: Refaeli, Yosef, et al.
Publicado: (2008)

The B cell receptor signaling pathway in mantle cell lymphoma
por: Merolle, Maria I., et al.
Publicado: (2018)

Gata3 restrains B cell proliferation and cooperates with p18(INK4c) to repress B cell lymphomagenesis
por: Liu, Shiqin, et al.
Publicado: (2016)

Phosphatidylserine synthesis controls oncogenic B cell receptor signaling in B cell lymphoma
por: Omi, Jumpei, et al.
Publicado: (2023)

A structural platform for B cell receptor signaling
por: Xie, Wei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gdbsgkl9874pkpvvc880o55jhd